Overview

The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults

Status:
Not yet recruiting
Trial end date:
2023-10-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the preventative antiviral activity of CD388, as compared to saline placebo, when administered as a single dose to healthy adult participants in a human viral challenge model of influenza.
Phase:
Phase 2
Details
Lead Sponsor:
Cidara Therapeutics Inc.
Collaborator:
Janssen Pharmaceuticals